Detection and viability of waterborne pathogens using a gut-on-chip. This project aims to resolve a significant problem for water utilities. Microbial pathogens Cryptosporidium, norovirus and adenovirus are the main public health concern for drinking water in developed nations. Water monitoring is limited by the lack of fast, reliable detection methods and viability assays for these pathogens. This project will use a novel gut-on-a-chip to develop for the first time rapid infectivity assays for ....Detection and viability of waterborne pathogens using a gut-on-chip. This project aims to resolve a significant problem for water utilities. Microbial pathogens Cryptosporidium, norovirus and adenovirus are the main public health concern for drinking water in developed nations. Water monitoring is limited by the lack of fast, reliable detection methods and viability assays for these pathogens. This project will use a novel gut-on-a-chip to develop for the first time rapid infectivity assays for Cryptosporidium, norovirus and adenovirus. Significant benefits include improved diagnostics and water disinfection assays, improved water treatment and reduced costs with global impact.Read moreRead less
Lizard social networks and the spread of parasites. Australian ecosystems are continually threatened by new epidemics of diseases and parasites, some local, others from overseas. Examples include the facial tumours of Tasmanian devils and the fungus that threatens many native frog species. To manage these epidemics effectively, we must understand how they spread through animal populations. This project will help to protect our fauna from invasive diseases. It contributes to sustaining the biodiv ....Lizard social networks and the spread of parasites. Australian ecosystems are continually threatened by new epidemics of diseases and parasites, some local, others from overseas. Examples include the facial tumours of Tasmanian devils and the fungus that threatens many native frog species. To manage these epidemics effectively, we must understand how they spread through animal populations. This project will help to protect our fauna from invasive diseases. It contributes to sustaining the biodiversity of the country. With better knowledge of how diseases of wildlife spread, we can develop more effective control of those diseases thereby protecting wildlife species, animal populations and, ultimately, Australian ecosystems.Read moreRead less
Phylogeography, evolution and taxonomy of humanity's greatest pest, Rattus rattus: Epidemiological, archaeological and conservation implications. This project will characterise a major threat to Australian biosecurity and health, and identify the range of likely disease risks associated with introductions of different 'strains' of black rat. It will provide critical data for management efforts around the world, especially for strategic partners in neighbouring Southeast Asian nations, as well as ....Phylogeography, evolution and taxonomy of humanity's greatest pest, Rattus rattus: Epidemiological, archaeological and conservation implications. This project will characterise a major threat to Australian biosecurity and health, and identify the range of likely disease risks associated with introductions of different 'strains' of black rat. It will provide critical data for management efforts around the world, especially for strategic partners in neighbouring Southeast Asian nations, as well as for conservation efforts within Australia. The data will also provide novel means to track the timing and routes of human prehistoric movements throughout the area. It will establish strategic research collaborations between researchers in zoological, medical, epidemiological, genetics, and conservation fields in a unique multi-disciplinary study.Read moreRead less
Functional characterisation of poly-histidine triad proteins. This project aims to understand the role and function of a novel family of surface proteins produced by Streptococci. These so-called polyhistidine triad proteins are known to contribute to capacity to cause disease in animals and humans, but we need to know how they work, as they may be excellent targets for novel drugs or vaccines.
Novel perspectives on the function of AB5 toxin B subunits in pathogenic bacterial. AB5 toxins are produced by bacteria that cause important diseases in humans and livestock. This project tests the hypothesis that the components of the toxins responsible for binding to host cells and tissues also directly contribute to cellular damage, thereby providing a better understanding of how AB5 toxin-producing bacteria cause disease.
New methods for integrating population structure and stochasticity into models of disease dynamics. Epidemics, such as the 2007 equine 'flu outbreak and 2009 swine 'flu pandemic, highlight the need to make informed decisive responses. This project will develop new methods that incorporate two important aspects of disease dynamics---host structure and chance---into mathematical models, and determine their impact in terms of controlling infections.
A single vaccine for influenza and pneumonia. Influenza and bacterial pneumonia collaborate to kill millions of people each year. This project aims to develop a single vaccine that will provide long-lasting protection against both influenza and pneumonia.
Investigating The Antimicrobial Activity Of Zinc At The Host-pneumococcal Interface
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Streptococcus pneumoniae is a human-only bacterium that is responsible for killing more than one million people every year. This project will analyse how the human immune system fights this bacterium, and subsequently, how the bacteria manages to subvert these attacks and survive in the human host. This will provide crucial information for developing new drugs against this pathogen, in an attempt to combat the ever-increasing problem of antibiotic resistance.
Vancomycin is the antibiotic we rely on for the treatment of major infections due to bacteria that are resistant to other antibiotics (MRSA). Vancomycin is monitored in each patient to individualise the dose. This is done to improve treatment efficacy, reduce adverse effects and to prevent antibiotic resistance. This project will introduce a vancomycin guideline and train hospital staff to use vancomycin safely, effectively and to minimise the development of resistance.
I am a molecular virologist researching the host response to hepatitis C virus (HCV) infection with the aim of understanding how the liver clears HCV infection. An understanding of this process will hopefully lead to novel antiviral strategies to combat not only HCV but a broad range of other viral infections.